Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study

Survival in patients less than 12 months remains excellent and stable even at long term, as a 10-year follow-up did not change the number of events. However, survival in MYCN-amplified tumors remained poor. Patients with metastatic tumors require accurate risk stratification. For each treatment group, there was no significant difference in long-term outcomes compared with previous publications from INES. No lethal toxicity affecting long-term survival occurred.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-08-18
DOI
https://doi.org/10.1002/pbc.31982
Citations
2
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
2.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study

Benoît Dumont, Ruth Lydia Ladenstein, Dominique Valteau‐Couanet, Kate Wheeler et al.
2 citations
Pediatric Blood & Cancer
Neuroblastoma Research and Treatments
2.78
article

Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study

Benoît Dumont, Ruth Lydia Ladenstein, Dominique Valteau‐Couanet, Kate Wheeler, Vanessa Segura, Andrea Di Cataldo, Adela Cañete, Riccardo Haupt, Anne Sophie Defachelles, Marion Gambart, Katia Mazzocco, Claudia Pasqualini, Bénédicte Brichard, Maja Beck‐Popovic, Gudrun Schleiermacher, D. Ramal, Alberto Garaventa, Carole Coze, Caroline Munzer, Stefania Sorrentino, Ana Lacerda, Julie Savagner
article en
2 citations

Abstract

Survival in patients less than 12 months remains excellent and stable even at long term, as a 10-year follow-up did not change the number of events. However, survival in MYCN-amplified tumors remained poor. Patients with metastatic tumors require accurate risk stratification. For each treatment group, there was no significant difference in long-term outcomes compared with previous publications from INES. No lethal toxicity affecting long-term survival occurred.

Pediatric Blood & CancerVol. 72(11)
Cliniques Universitaires Saint-Luc (BE), Inserm (FR), Aix-Marseille Université (FR), Université Paris Sciences et Lettres (FR), Istituto Giannina Gaslini (IT), Institut Gustave Roussy (FR), John Radcliffe Hospital (GB), Hospital Universitari i Politècnic La Fe (ES), University of Catania (IT), Institut d’Hématologie et d’Oncologie Pédiatrique (FR), Instituto Português de Oncologia Francisco Gentil (PT), St Anna Children's Hospital (AT), Mother Hospital (IN), Centre Oscar Lambret (FR), Hôpital des Enfants (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Hôpital de la Timone (FR), Instituto de Investigación Sanitaria La Fe (ES), Institut Curie (FR), University of Lausanne (CH)
Fondazione Italiana per la Lotta al Neuroblastoma, Ministero della Salute
Openalex Percentile: Top 9%
Neuroblastoma Research and Treatments
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.